| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3390506 | Rheumatic Disease Clinics of North America | 2007 | 25 Pages |
Abstract
Additional research is needed to establish the safety of biologic agents in pregnancy and lactation. The practitioner should convey information regarding the natural history of rheumatoid arthritis during pregnancy and safety issues related to pharmacotherapies to every woman of childbearing age with RA, well before conception and pregnancy, to ensure optimal outcomes.
Related Topics
Health Sciences
Medicine and Dentistry
Immunology, Allergology and Rheumatology
Authors
Amit Golding, Uzma J. Haque, Jon T. Giles,